Stem cell based gene therapy in prostate cancer

Jae Heon Kim1, Hong Jun Lee2, Yun Seob Song1

  • 1Department of Urology, Soonchunhyang University, College of Medicine, Soonchunyang University Hospital, Seoul 140-743, Republic of Korea.

Insights

Stem cell-based suicide gene therapy offers a safer alternative to traditional prostate cancer treatments by targeting cancer cells and minimizing systemic toxicity. This approach utilizes genetically engineered stem cells to deliver therapeutic agents directly to tumors.

Area of Science:

  • Oncology
  • Gene Therapy
  • Stem Cell Biology

Background:

  • Current prostate cancer treatments, particularly for hormone-refractory cases, often involve cytotoxic agents with significant adverse effects.
  • Classic suicide gene therapy, while targeting cancer cells, can cause immune compromise due to viral vectors.

Purpose of the Study:

  • To review the mechanisms and limitations of stem cell-based suicide gene therapy for prostate cancer.
  • To explore stem cells as advanced cellular vectors for targeted cancer treatment.

Main Methods:

  • Review of existing literature on stem cell-mediated gene therapy for prostate cancer.
  • Analysis of various prodrug systems employed with stem cells, including cytosine deaminase/5-fluorocytosine and herpes simplex virus thymidine kinase/ganciclovir.

Main Results:

  • Stem cells, particularly mesenchymal and neural stem cells, exhibit homing effects beneficial for targeted cancer therapy.
  • Stem cell-based suicide gene therapy activates prodrugs within the tumor mass, reducing systemic toxicity and potentially eliminating resistant cancer cells and therapeutic stem cells.

Conclusions:

  • Genetically engineered stem cells represent a promising and safer platform for prostate cancer gene therapy.
  • Further research is needed to fully elucidate the mechanisms and overcome the limitations of stem cell-based approaches in prostate cancer treatment.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy00:59

Gene Therapy

4.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K